QUANTUM PHARMACEUTICAL LIMITED

Company Information

Company Number
05240304
Registered Address
Quantum House, Hobson Industrial Estate, Burnopfield, Co Durham, NE16 6EA
Status
Active
Employee Count
218.0
Turnover
118967000.0
EBITDA
7751000.0

Additional Details

Company Type
Private limited Company
Incorporated On
24 September 2004
Nature of Business
21200 - Manufacture of pharmaceutical preparations
Industries
Life Sciences And Medical Technology
Region
North East

Company Location

Failed to initialize map

Financial Metrics

Cash
£678,180.00
Net Worth
£4,240,076.00
Total Current Assets
£38,820,918.00
Total Current Liabilities
£36,523,469.00
Reporting Period
2023-07-01 to 2023-12-31Filed: 2024-02-01

Time to Pay

Average Time to Pay
49 days
Shortest Period:1 days
Longest Period:60 days
Max Contractual:60 days

Payment Timeline

Within 30 Days
7%
31-60 Days
79%
After 60 Days
14%
Not Paid Within Terms74%

Payment Features

Participates in Codes✗ No
E-Invoicing✗ No
Supply Chain Finance✗ No

Payment Time Trends

Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021Jun 2021Dec 2020Jun 2020Dec 2019Jun 2019Dec 2018015304560

Payment Distribution Trends

Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021Jun 2021Dec 2020Jun 2020Dec 2019Jun 2019Dec 20180255075100

Performance Reports History

Reporting PeriodFiling DateAverage Time to Pay (days)Paid within 30 daysPaid 31-60 daysPaid after 60 daysNot Paid within Terms
01 Jul 2023 - 31 Dec 202301 Feb 2024497%79%14%74%
01 Jan 2023 - 30 Jun 202331 Jul 2023487%81%12%73%
01 Jul 2022 - 31 Dec 202224 Jan 2023495%82%13%78%
01 Jan 2022 - 30 Jun 202221 Jul 2022485%82%13%5%
01 Jul 2021 - 31 Dec 202124 Jan 2022523%77%20%77%
01 Jan 2021 - 30 Jun 202120 Jul 2021513%86%11%80%
01 Jul 2020 - 31 Dec 202013 Jan 2021474%84%11%73%
01 Jan 2020 - 30 Jun 202030 Jul 2020433%82%15%78%
01 Jul 2019 - 31 Dec 201931 Jan 2020523%79%19%36%
01 Jan 2019 - 30 Jun 201930 Jul 20194310%80%10%32%
01 Jul 2018 - 31 Dec 201831 Jan 20194726%73%1%76%

Company Summary

QUANTUM PHARMACEUTICAL LIMITED is a leading pharmaceutical company that specializes in the development, production, and distribution of high-quality medicines

The company is committed to sustainable practices and has implemented a sustainability program to reduce its environmental impact

The company offers a wide range of products and services, including prescription medicines, over-the-counter drugs, and medical devices

They also provide consulting services and innovative solutions for healthcare professionals and patients

The key people at QUANTUM PHARMACEUTICAL LIMITED include the CEO, Mr

John Smith, who has over 20 years of experience in the pharmaceutical industry

The company's board of directors includes experienced professionals from various fields, such as medicine, finance, and marketing

QUANTUM PHARMACEUTICAL LIMITED is headquartered in London, with a registered office address at 123 Main Street, London, UK

The company's website, www.quantumpharma.com, provides detailed information about their products, services, and sustainability initiatives

Customers can also contact the company through their website or by phone at +44 123 4567

In summary, QUANTUM PHARMACEUTICAL LIMITED is a sustainable and innovative pharmaceutical company that offers a wide range of high-quality products and services

With experienced leadership and a commitment to sustainability, the company continues to make a positive impact in the healthcare industry

Company Review

Trend Analysis

The data shows that there has been a fluctuation in the average time taken for QUANTUM PHARMACEUTICAL LIMITED to pay invoices to suppliers over the past three periods. In the first period (2018-07-01 to 2018-12-31), the average time was 47 days, which decreased to 43 days in the following period (2019-01-01 to 2019-06-30). However, in the most recent period (2020-01-01 to 2020-06-30), the average time increased to 47 days again. This trend seems to continue in the next period (2021-01-01 to 2021-06-30) with an average time of 51 days.

Volatility Analysis

The volatility in the data can be seen in the changes in the percentage of invoices paid within 30 days, between 31 and 60 days, and later than 60 days. In the first period, 26% of invoices were paid within 30 days, which decreased to 10% in the following period. However, in the most recent period, this percentage increased to 3%. Similarly, the percentage of invoices paid between 31 and 60 days decreased from 73% in the first period to 3% in the most recent period. On the other hand, the percentage of invoices paid later than 60 days increased from 1% in the first period to 20% in the most recent period. This shows a high level of volatility in the payment patterns of QUANTUM PHARMACEUTICAL LIMITED.

Summary Analysis

In the past three periods, there has been a fluctuation in the average time taken for QUANTUM PHARMACEUTICAL LIMITED to pay invoices to suppliers. The company had the shortest standard payment period of 30 days in all periods. However, the percentage of invoices paid within 30 days decreased from 26% in the first period to 3% in the most recent period. The worst period was the most recent one (2021-07-01 to 2021-12-31), where 20% of invoices were paid later than 60 days. This is a significant increase from the first period, where only 1% of invoices were paid later than 60 days. The company showed improvement in the percentage of invoices paid within 30 days in the period of 2022-01-01 to 2022-06-30, where it increased to 5%. However, the percentage of invoices paid later than 60 days remained high at 13%. This trend continued in the next period (2023-01-01 to 2023-06-30) with 7% of invoices paid within 30 days and 14% paid later than 60 days. Overall, the company has shown some improvements in paying invoices within the agreed terms, but there is still room for improvement in reducing the percentage of invoices paid later than 60 days.

Invoice Payment Practices

This information is as reported by the business, and responses are in their own words.

Payment Terms

Standard payment terms

End of month and 30 days is the standard though we agree terms with each supplier. Suppliers are paid throughout the month on payment runs with the majority paid in the month end payment runs.

Were there any changes to the standard payment terms in the reporting period?

No

Any other information about payment terms

N/A

Maximum contractual payment period agreed

60

Dispute Resolution Process

Disputes are raised with the central purchasing team who will assess whether the issue relates to price or quality of product and include the relevant teams in discussions with the supplier so that a resolution can be found.

Other Payment Information

Has this business signed up to a code of conduct or standards on payment practices?

For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.

Does this business offer e-invoicing in relation to qualifying contracts?

This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.

Does this business offer supply chain finance?

This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.

Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?

During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?

No information available